Literature DB >> 7396653

Hypothalamic-pituitary-adrenal axis activity in depressive illness. Its relationship to classification.

M A Schlesser, G Winokur, B M Sherman.   

Abstract

Serum cortisol response to the 1-mg overnight dexamethasone suppression test was studied in 221 depressed patients and 109 nondepressed psychiatric controls. Nonsuppression distinguished patients with primary unipolar depression (65/146) from patients with secondary unipolar depression (0/42) and nondepressed controls (0/109). Furthermore, nonsuppression distinguished the three familial subtypes of primary unipolar depressive illness: familial pure depressive disease (FPDD; 38/50 patients), sporadic depressive disease (SDD; 24/55 patients), and depression spectrum disease (3/41 patients). Moderate elevations in baseline serum cortisol levels were found in FPDD, SDD, and bipolar depression. Medication did not affect the results. The data suggest that the depressive syndrome is composed of separate illnesses, each of which has a distinctive pattern of hypothalamic-pituitary-adrenal axis activity during the depressed state as well as a specific clinical and familial psychiatric history.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7396653     DOI: 10.1001/archpsyc.1980.01780200015001

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  17 in total

1.  Plasma cortisol in first episode drug-naïve mania: differential levels in euphoric versus irritable mood.

Authors:  Leandro L Valiengo; Márcio G Soeiro-de-Souza; Andrea H Marques; Doris H Moreno; Mário F Juruena; Ana Cristina Andreazza; Wagner F Gattaz; Rodrigo Machado-Vieira
Journal:  J Affect Disord       Date:  2012-02-02       Impact factor: 4.839

2.  Combined biological tests for suicide prediction.

Authors:  William Coryell; Michael Schlesser
Journal:  Psychiatry Res       Date:  2007-02-07       Impact factor: 3.222

3.  Decrease in plasma levels of 3,4-dihydroxyphenylethyleneglycol in major depression.

Authors:  B Scatton; H Loo; T Dennis; C Benkelfat; C Gay; M F Poirier-Littre
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

Review 4.  [Factors interfering with the dexamethasone suppression test].

Authors:  R Liebl
Journal:  Klin Wochenschr       Date:  1986-06-16

5.  Distribution of corticotropin-releasing factor receptors in primate brain.

Authors:  M A Millan; D M Jacobowitz; R L Hauger; K J Catt; G Aguilera
Journal:  Proc Natl Acad Sci U S A       Date:  1986-03       Impact factor: 11.205

6.  Melatonin/cortisol ratio in psychiatric illness.

Authors:  I N Ferrier; E C Johnstone; T J Crow; J Arendt
Journal:  Lancet       Date:  1982-05-08       Impact factor: 79.321

7.  A randomised controlled study of risperidone and olanzapine for schizophrenic patients with neuroleptic-induced acute dystonia or parkinsonism.

Authors:  H Y Chan; C J Chang; S C Chiang; J J Chen; C H Chen; H J Sun; H G Hwu; M S Lai
Journal:  J Psychopharmacol       Date:  2008-09-18       Impact factor: 4.153

8.  The dexamethasone suppression test in dementia.

Authors:  G Magni; F Schifano; D De Leo; O Zangaglia
Journal:  Ital J Neurol Sci       Date:  1987-04

9.  Neurotic depression: a diagnosis based on preexisting characteristics.

Authors:  G Winokur; D W Black; A Nasrallah
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1987

10.  Sleep during mania in manic-depressive males.

Authors:  P Linkowski; M Kerkhofs; C Rielaert; J Mendlewicz
Journal:  Eur Arch Psychiatry Neurol Sci       Date:  1986
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.